American Healthcare REIT, Inc. Files 8-K and Announces New At-The-Market Equity Offering Program

Key Highlights

• New At-The-Market Equity Offering Program: American Healthcare REIT, Inc. (“the Company”) has entered into a Sales Agreement with several major financial institutions, including BofA Securities, Barclays, Citigroup, Citizens JMP Securities, Credit Agricole, Fifth Third Securities, KeyBanc Capital Markets, Morgan Stanley, RBC Capital Markets, Regions Securities, and others.
• Purpose of the Equity Program: The Company may offer and sell shares of its common stock through these agents, with proceeds expected to be used for general corporate purposes. These may include repaying or repurchasing indebtedness, working capital, capital expenditures, or potential future investments.
• Prospectus Supplement Filed: Any shares offered will be pursuant to a prospectus supplement dated February 27, 2026, and a related base prospectus, both filed with the SEC.
• Strong Compliance and Transparency: The Company commits to strict compliance with SEC regulations, timely filings, and robust internal controls and disclosure procedures. It will provide detailed updates to agents and investors at key reporting dates, and will not offer or sell shares during blackout periods or when in possession of material nonpublic information.
• Well-Known Seasoned Issuer Status: The Company confirms it qualifies as a “well-known seasoned issuer,” providing it with broad flexibility and credibility in the public markets.
• Use of Proceeds: Proceeds from sales will be used in line with disclosures made in the registration statement, with a focus on strengthening the balance sheet and supporting growth initiatives.
• Listing Commitment: The Company will use its best efforts to maintain listing of the shares on the New York Stock Exchange (NYSE).
• Enhanced Due Diligence and Investor Protection: Multiple mechanisms for due diligence, internal control reviews, and regular updates to agents and investors are built into the agreement to ensure transparency and compliance.

Potentially Price-Sensitive Information for Shareholders

• Market Impact of Equity Issuance: The launch of a new at-the-market equity offering program has the potential to impact share supply and, therefore, share price. Investors should consider the dilutive effect of possible new share issuances.
• Use of Proceeds: Funds raised may be allocated to strategic investments or debt reduction, which could positively influence the Company’s financial flexibility and future growth prospects.
• Regulatory and Reporting Safeguards: The Company has outlined detailed reporting and compliance safeguards, including blackout periods for share sales around earnings announcements and a commitment to file timely and accurate disclosures. These measures are designed to protect investors and maintain market integrity.
• Disclosure of Material Events: The Company will not permit share sales if in possession of material non-public information and will require public disclosure or SEC filings before any such sales resume.
• Internal Controls and Audit Oversight: The Company asserts its internal controls and disclosure procedures are effective, with no material weaknesses reported since the last audited fiscal year. This should provide confidence in the accuracy of financial reporting.
• No Material Adverse Change: The Company states that since its last report, there has been no material adverse change in its business, operations, or prospects, which should reassure investors about business stability.

Details for Investors

Under the new Sales Agreement, American Healthcare REIT, Inc. has empowered a syndicate of top-tier financial institutions to sell newly issued shares directly into the market at prevailing prices, rather than through a traditional underwritten offering. This approach allows the Company to raise capital efficiently and opportunistically, based on market conditions and capital needs.

The proceeds from any such offering will be directed towards general corporate uses, with explicit mention of repaying or repurchasing debt, funding working capital, making capital expenditures, and pursuing potential future investments. This financial flexibility may support both near-term liquidity and longer-term growth strategies.

The Company has put in place robust compliance protocols, including blackout windows around earnings releases and SEC filings, and a promise not to sell or instruct agents to sell shares when in possession of material non-public information. In the event the Company wishes to sell shares during these blackout periods, it will first file a Current Report on Form 8-K with detailed financial information and obtain agent consent, ensuring full transparency to investors.

The agreement also requires the Company to maintain up-to-date officers’ certificates, legal opinions, and comfort letters from auditors at various key dates, and to cooperate with thorough due diligence reviews. This provides additional layers of assurance for both investors and sales agents regarding the integrity of disclosures and financial statements.

The Company has confirmed that it is a well-known seasoned issuer under SEC rules and that neither it nor its subsidiaries are required or will be required to register as investment companies under the Investment Company Act as a result of the offering. The Company’s shares will continue to be listed on the NYSE, supporting liquidity and visibility for investors.

Finally, the Company represents that it has experienced no material adverse change in its business or prospects since its last reporting date and that all financial statements and disclosures are accurate and comply with all relevant SEC regulations.

Conclusion

The initiation of an at-the-market equity offering program is a significant development for American Healthcare REIT, Inc. It provides the Company with greater financial flexibility and the potential to strengthen its balance sheet, but also introduces the possibility of share dilution that investors should monitor. The comprehensive compliance and transparency measures, as well as the commitment to maintain robust internal controls and NYSE listing, should provide investors with added confidence.

Shareholders are encouraged to review the prospectus supplement and related filings for further details and to monitor future disclosures for updates on share issuance and use of proceeds.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisor and review all relevant SEC filings before making any investment decisions. The information provided herein is based on the Company’s filings and is believed to be accurate as of the date of publication but is subject to change without notice.

View American Healthcare REIT, Inc. Historical chart here